In all three groups, the fasting insulin levels (μIU/mL) were significantly lower compared to the values 3 h after glucose administration (measured at 0 and 180 min), respectively—MetS—7.83, 10.32; Exenatide—4.23, 6.49; Dulaglutide—3.99, 5.47) (Figure 1D). This evidence concerns the gene INS and metabolic syndrome.